Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Frankfurt - Delayed Quote EUR

Globus Medical, Inc. (GM0N.F)

Compare
64.50
-3.00
(-4.44%)
At close: April 4 at 8:11:22 AM GMT+2
Loading Chart for GM0N.F
  • Previous Close 67.50
  • Open 64.50
  • Bid 63.00 x 10000
  • Ask 63.50 x 10000
  • Day's Range 64.50 - 64.50
  • 52 Week Range 46.60 - 90.50
  • Volume 5
  • Avg. Volume 76
  • Market Cap (intraday) 8.573B
  • Beta (5Y Monthly) 1.29
  • PE Ratio (TTM) 94.85
  • EPS (TTM) 0.68
  • Earnings Date May 5, 2025 - May 9, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. The company offers musculoskeletal solutions, including spine products, such as traditional fusion implants, and treatment options for motion preservation technologies, and interventional solutions to treat vertebral compression fractures; orthopedic trauma solutions, which includes fracture plating, intramedullary nailing, and regenerative biologic products; hip and knee joint solutions, including modular hip stems and acetabular cups for total hip arthroplasty, as well as posterior stabilizing and cruciate retaining knee arthroplasty implants; and neuromonitoring services, which provides onsite and remote monitoring of the neurological systems of patients undergoing spinal and brain-related surgeries. The company also offers enabling technologies, such as imaging, navigation, and robotics (INR) solutions for assisted surgery, which includes the ExcelsiusGPS platform, a robotic guidance and navigation system for minimally invasive and open procedures with screw and interbody spacer placement applications; Surgimap, a surgical planning software platform; Excelsius3D, a platform combined with ExcelsiusGPS that provides an intraoperative, image-guided robotic navigation solution; ExcelsiusHub, which provides real-time patient array monitoring, tissue sparing drills, and registration flexibility; and ExcelsiusFlex, a total knee arthroplasty robotic solution. Further, it distributes human cell, tissue, and cellular and tissue-based products. The company sells its products through direct or distributor sales representatives, as well as hip and knee products through independent sales agents. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania.

www.globusmedical.com

5,300

Full Time Employees

December 31

Fiscal Year Ends

Recent News: GM0N.F

View More

Performance Overview: GM0N.F

Trailing total returns as of 4/4/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

GM0N.F
18.87%
S&P 500 (^GSPC)
13.73%

1-Year Return

GM0N.F
33.82%
S&P 500 (^GSPC)
1.42%

3-Year Return

GM0N.F
6.52%
S&P 500 (^GSPC)
10.72%

5-Year Return

GM0N.F
72.46%
S&P 500 (^GSPC)
103.89%

Compare To: GM0N.F

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: GM0N.F

View More

Valuation Measures

Annual
As of 4/4/2025
  • Market Cap

    8.57B

  • Enterprise Value

    8.25B

  • Trailing P/E

    94.97

  • Forward P/E

    20.70

  • PEG Ratio (5yr expected)

    1.88

  • Price/Sales (ttm)

    3.90

  • Price/Book (mrq)

    2.35

  • Enterprise Value/Revenue

    3.62

  • Enterprise Value/EBITDA

    19.24

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    4.09%

  • Return on Assets (ttm)

    5.33%

  • Return on Equity (ttm)

    2.52%

  • Revenue (ttm)

    2.52B

  • Net Income Avi to Common (ttm)

    102.98M

  • Diluted EPS (ttm)

    0.68

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    890.06M

  • Total Debt/Equity (mrq)

    12.87%

  • Levered Free Cash Flow (ttm)

    598.37M

Research Analysis: GM0N.F

View More

Company Insights: GM0N.F

Research Reports: GM0N.F

View More

People Also Watch